Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

OBJECTIVE: To evaluate the efficacy and safety of Hua Shi Bai Du Granule (Q-14) plus standard care compared with standard care alone in adults with coronavirus disease (COVID-19). STUDY DESIGN: A single-center, open-label, randomized controlled trial. SETTING: Wuhan Jinyintan Hospital, Wuhan, China,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Yang, Wei, Liu, Yue, Lu, Cheng, Ruan, Lianguo, Zhao, Chen, Huo, Ruili, Shen, Xin, Miao, Qing, Lv, Wenliang, Li, Hao, Shi, Huaxin, Hu, Lijie, Yang, Zhixu, Zhang, Li, Wang, Bing, Dong, Guoju, Xian, Yongyue, Li, Bin, Zhou, Zhenqi, Xu, Chunyan, Chen, Yingying, Bian, Yongjun, Guo, Jing, Yang, Jinliang, Wang, Jian, Qi, Wensheng, Chen, Suping, Chen, Yang, Yan, Bei, Wang, Wei, Li, Jing, Xie, Xiaolei, Xu, Ming, Jiang, Jianxin, Wang, Gang, Cong, Xiaodong, Zhu, Haoning, Shi, Jiaheng, Leng, Luxing, Li, Dongxu, Guo, Lanping, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285932/
https://www.ncbi.nlm.nih.gov/pubmed/34425471
http://dx.doi.org/10.1016/j.phymed.2021.153671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285932/
https://www.ncbi.nlm.nih.gov/pubmed/34425471
http://dx.doi.org/10.1016/j.phymed.2021.153671

Ejemplares similares